Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Advanced Drug Development a Reality with UK's Most Powerful Nuclear Magnetic Resonance Facility

By LabMedica International staff writers
Posted on 30 Nov 2010
UK researchers are gaining new insights into vital high tech engineering materials and novel pharmaceuticals due to the creation of the UK's most powerful nuclear magnetic resonance (NMR) device for solids now sited in a national research facility.

The new UK 850 MHz Solid-State NMR Facility at the University of Warwick's (UK) Center for Magnetic Resonance was launched in the University's Millburn House on October 28, 2010. More...
It is a national facility open to a large range of researchers across the United Kingdom and has been made possible by the award of a GBP 3.7 million grant from the Engineering and Physical Sciences Research Council (EPSRC; Swindon, Wiltshire, UK) and the Biotechnology and Biological Sciences Research Council (BBSRC; Swindon, Wiltshire, UK).

The new facility was formally launched by David Delpy, the chief executive of EPSRC at a special event, which was attended by researchers from all the main facility partners (Universities of Warwick, Cambridge, Durham, Nottingham, Glasgow, and St. Andrews). David Delpy said, "The EPSRC are pleased to have supported the UK's internationally leading research for over 15 years. NMR spectroscopy is a vital analytical tool science. It is a powerful technique that can provide detailed information on the topology, dynamics, and three-dimensional structure of molecules in solution and the solid state.”

Prof. Mark Smith, deputy vice-chancellor of the University of Warwick, said, "This facility provides a significant leap in the capability available to the UK's NMR spectroscopy researchers that allows us to compete with the very best in the world. This was possible through the coordinated efforts of a wide range of researchers and funders and is a model of such a partnership for developing such facilities for the UK in the future. It is certain to provide us with new insights into everything from potential new pharmaceuticals to innovate materials for the next generation of catalytic convertors.”

Related Links:
University of Warwick
UK Engineering and Physical Sciences Research Council
UK Biotechnology and Biological Sciences Research Council


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.